Revenue for the quarter was $32.50 million with operating income of $87.70 million.
The Newhaven, Connecticut (CT)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $511 million.
Also read:
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here.